AW-16-2259_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 6-chloro-3-(3-(dimethylamino)propyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one, NOX2 inhibitors targeting CYBB (Novartis, 16384282)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/16384282
Similar Terms
Downloads & Tools

Genes

17 genes differentially expressed following the AW-16-2259_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
TMSB10 thymosin beta 10 0.899467
LGALS1 lectin, galactoside-binding, soluble, 1 0.463384
NME1 NME/NM23 nucleoside diphosphate kinase 1 0.398137
APRT adenine phosphoribosyltransferase 0.358459
MCM4 minichromosome maintenance complex component 4 0.327615
RPS29 ribosomal protein S29 0.297439
ROMO1 reactive oxygen species modulator 1 0.28562
RPL38 ribosomal protein L38 0.262659
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 0.221137

decreased expression

Symbol Name Standardized Value
SMG7 SMG7 nonsense mediated mRNA decay factor -0.463384
DOHH deoxyhypusine hydroxylase/monooxygenase -0.364638
PSMF1 proteasome (prosome, macropain) inhibitor subunit 1 (PI31) -0.322162
UBAP2L ubiquitin associated protein 2-like -0.286894
AP3D1 adaptor-related protein complex 3, delta 1 subunit -0.286894
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.269034
PDLIM7 PDZ and LIM domain 7 (enigma) -0.251436
PKM pyruvate kinase, muscle -0.227693